U.S. markets open in 2 hours 2 minutes
  • S&P Futures

    4,260.25
    +4.25 (+0.10%)
     
  • Dow Futures

    34,182.00
    +100.00 (+0.29%)
     
  • Nasdaq Futures

    14,372.00
    +17.75 (+0.12%)
     
  • Russell 2000 Futures

    2,334.40
    +3.20 (+0.14%)
     
  • Crude Oil

    73.12
    -0.18 (-0.25%)
     
  • Gold

    1,782.90
    +6.20 (+0.35%)
     
  • Silver

    26.23
    +0.18 (+0.67%)
     
  • EUR/USD

    1.1949
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.4870
    0.0000 (0.00%)
     
  • Vix

    16.02
    -0.30 (-1.84%)
     
  • GBP/USD

    1.3900
    -0.0021 (-0.15%)
     
  • USD/JPY

    110.7400
    -0.0950 (-0.09%)
     
  • BTC-USD

    33,540.17
    -80.53 (-0.24%)
     
  • CMC Crypto 200

    798.87
    +12.25 (+1.56%)
     
  • FTSE 100

    7,118.96
    +8.99 (+0.13%)
     
  • Nikkei 225

    29,066.18
    +190.95 (+0.66%)
     

Avinger to Announce Fourth Quarter 2019 Financial Results on March 5, 2020

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

REDWOOD CITY, CA / ACCESSWIRE / February 27, 2020 / Avinger, Inc. (AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that it will release its financial results for the fourth quarter 2019 after the close of trading on Thursday, March 5, 2020. The Company will host a conference call beginning at 1:30 pm PT/4:30 pm ET.

Individuals interested in listening to the conference call may do so by dialing 844-369-8774 for domestic callers or +1-862-298-0844 for international callers. To listen to a live webcast, please visit http://www.avinger.com and select Investor Relations.

A replay of the call will be available beginning March 5, 2020 at approximately 7:30 pm PT/10:30 pm ET through March 12, 2020. To access the replay, dial 919-882-2331 and reference Conference ID: 33338. The webcast will also be available on Avinger's website following completion of the call at www.avinger.com.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Investor Contact:

Mark Weinswig
Chief Financial Officer
Avinger, Inc.
(650) 241-7916
ir@avinger.com

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.



View source version on accesswire.com:
https://www.accesswire.com/578069/Avinger-to-Announce-Fourth-Quarter-2019-Financial-Results-on-March-5-2020